SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 34.71

Change

+1.61 (+4.86)%

Market Cap

N/A

Volume

2.18M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+4.61 (+0.94%)

USD 121.60B
REGN Regeneron Pharmaceuticals Inc

-16.67 (-2.03%)

USD 92.70B
ARGX argenx NV ADR

+5.40 (+0.91%)

USD 35.81B
ALNY Alnylam Pharmaceuticals Inc

-4.35 (-1.62%)

USD 34.69B
BGNE BeiGene Ltd

+1.81 (+0.93%)

USD 22.85B
MRNA Moderna Inc

-1.33 (-3.06%)

USD 21.00B
UTHR United Therapeutics Corporatio..

-0.42 (-0.10%)

USD 16.70B
RPRX Royalty Pharma Plc

-0.15 (-0.58%)

USD 16.11B
INCY Incyte Corporation

-0.10 (-0.12%)

USD 14.67B
SMMT Summit Therapeutics PLC

-1.29 (-6.21%)

USD 13.75B

ETFs Containing SWTX

FLI:CA CI U.S. & Canada Lifeco C.. 9.98 % 0.92 %

-0.03 (0.57%)

CAD 0.09B
HFIN:CA Hamilton Enhanced Canadia.. 9.95 % 0.00 %

+0.11 (+0.57%)

CAD 0.17B
CEW:CA iShares Equal Weight Banc.. 9.92 % 0.60 %

+0.04 (+0.57%)

CAD 0.23B
HEF:CA 7.65 % 0.83 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 3.62 % 0.00 %

-0.03 (0.57%)

CAD 0.38B
CDEF:CA Manulife Smart Defensive .. 2.59 % 0.00 %

N/A

CAD 1.40M
TLV:CA Invesco S&P/TSX Composite.. 2.20 % 0.34 %

+0.05 (+0.57%)

CAD 0.08B
HPR:CA Global X Active Preferred.. 1.93 % 0.63 %

+0.02 (+0.57%)

CAD 1.00B
XMD:CA iShares S&P/TSX Completio.. 1.87 % 0.61 %

-0.03 (0.57%)

CAD 0.23B
DXM:CA 0.00 % 0.67 %

N/A

N/A
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

+0.03 (+0.57%)

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

-0.12 (0.57%)

N/A
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

-0.04 (0.57%)

CAD 0.28B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

+0.12 (+0.57%)

N/A
FICS First Trust International.. 0.00 % 0.00 %

-0.12 (0.57%)

USD 0.15B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.90% 58% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.90% 58% F 40% F
Trailing 12 Months  
Capital Gain 57.27% 75% C 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.27% 75% C 84% B
Trailing 5 Years  
Capital Gain 87.02% 83% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 87.02% 82% B 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 22.26% 66% D+ 75% C
Dividend Return 22.26% 66% D+ 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 71.43% 50% F 28% F
Risk Adjusted Return 31.16% 85% B 63% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector